FDA 483 - Epitope Diagnostics, Inc. - April 28, 2023

An FDA inspection of Epitope Diagnostics, Inc. in San Diego, CA, revealed two significant issues related to quality system procedures. The firm failed to develop written procedures for Medical Device Reports and inadequately established procedures for receiving, reviewing, and evaluating complaints. These observations indicate deficiencies in the firm's quality management system for medical device manufacturing.